Solving a real clinical need with an attractive solution
Home
Company Focus
Natural cardiovascular restoration
Cardiovascular disease is the #1 cause of death.
Bypass Graft surgery restores blood flow by diverting blood around section of blocked arteries using vascular graft.
1.5 million bypass surgeries performed each year worldwide, requiring >3 million grafts.
80% of all implanted grafts are saphenous veins, harvested from the legs of the patient, associated to wound healing complications, pain, and high cost.
50-60% of all implanted grafts fail within 10 years, requiring repeat surgery.
Our Technology
Natural Tissue Restoration
BioDGraft eliminates the need for vessel harvesting: No additional wound, no risk of infection, no pain.
Door-opener for people with severe diabetes, varicose veins, and amputations.
Shorter hospital stay, at least 1 day less.
Significantly decreased procedure time for the surgical team.
Less cost.
BioDGraft has the potential to become a graft for life:
revolutionary product design and polymer technology, developed by researchers at TU and Medical University of Vienna
Microporous scaffold allowing fast cell infiltration.
Long-term patency due to natural endogenous tissue restoration and absorbable polymer, no long-term synthetic remnants → reduced risk of graft stenosis, calcification and need for re-operation.
BIODGRAFT, AN NLC VENTURE, SETS OUT TO ELIMINATE THE NEED FOR VEIN HARVESTING IN BYPASS SURGERIES, PROPOSING A SOLUTION THAT LASTS FOR LIFE. Cardiovascular disease